Viewing StudyNCT00147316



Ignite Creation Date: 2024-05-05 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00147316
Status: COMPLETED
Last Update Posted: 2012-03-01
First Post: 2005-09-05

Brief Title: Japan Alteplase Clinical Trial J-ACT Efficacy and Safety Study of Tissue Plasminogen Activator Alteplase for Ischemic Stroke
Sponsor:
Organization: Mitsubishi Tanabe Pharma Corporation

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 103
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: